Insights

  • Date

  • Content Type

  • Reset

Blog

The Risk-Reward Conundrum

30.03.22

By Dr. Diane Seimetz

Opportunities and challenges of bringing innovative therapies to market.

Read More

Blog

Happily ever after: Why scientific due diligence is key to a successful M&A marriage

23.02.22

By Dr. Diane Seimetz

Why scientific due diligence is key to a successful M&A

Read More

Blog

Extracellular vesicles in drug delivery – Understanding their potential and challenges

11.02.22

By Jörg Schneider

The field of extracellular vesicles is a nascent and rapidly..

Read More

Blog

Accelerating development through manufacturing best practices

17.01.22

By Kate Coleman, MSc.

The journey to commercialization can be fraught with challenges for organizations...

Read More

Blog

The Promise of Converging Disruptive Technologies in Advanced Therapy Production

11.01.22

By Yasser El-Sherbini

Advanced therapeutic medicinal products (ATMPs), better known as cell and gene therapy (CGT) in the United States...

Read More

Blog

Roadmap to commercialization success: Build agility into drug development plans

29.11.21

By Dr. Diane Seimetz

We know the lifechanging impact that gene, cell and tissue-based therapies..

Read More

We are now Cencora PharmaLex 

PharmaLex is now part of Cencora, a leading global healthcare company with a foundation in pharmaceutical distribution. In 2024 and beyond PharmaLex and all the companies in PharmaLex family will begin a journey to becoming Cencora as well. Cencora brings the companies and services together under one new name. The name will change, but the level of attention and service you receive remains the same.  

Know more